These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10839746)

  • 1. Chlamydia, inflammation, and atherogenesis.
    Rosenfeld ME; Blessing E; Lin TM; Moazed TC; Campbell LA; Kuo C
    J Infect Dis; 2000 Jun; 181 Suppl 3():S492-7. PubMed ID: 10839746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice.
    May AE; Redecke V; Grüner S; Schmidt R; Massberg S; Miethke T; Ryba B; Prazeres da Costa C; Schömig A; Neumann FJ
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):789-94. PubMed ID: 12663369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of C. pneumoniae infection and atherosclerosis.
    Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C
    J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response.
    Penttilä T; Haveri A; Tammiruusu A; Vuola JM; Lahesmaa R; Puolakkainen M
    Microb Pathog; 2008 Jul; 45(1):25-9. PubMed ID: 18456450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Moazed TC; Campbell LA; Rosenfeld ME; Grayston JT; Kuo CC
    J Infect Dis; 1999 Jul; 180(1):238-41. PubMed ID: 10353889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of Chlamydia pneumoniae with human endothelial cells.
    Summersgill JT; Molestina RE; Miller RD; Ramirez JA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S479-82. PubMed ID: 10839743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells.
    Yang X; Coriolan D; Schultz K; Golenbock DT; Beasley D
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2308-14. PubMed ID: 16179594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae and atherosclerosis.
    Campbell LA; Kuo CC
    Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chlamydia pneumoniae--chronic infection and atherosclerosis].
    Tiran B
    Wien Med Wochenschr; 2001; 151(24):590-3. PubMed ID: 11820175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae and atherosclerosis: the role of mast cells.
    Di Pietro M; Schiavoni G; Del Piano M; Shaik Y; Boscolo P; Caraffa A; Grano M; Teté S; Conti F; Sessa R
    J Biol Regul Homeost Agents; 2009; 23(2):65-9. PubMed ID: 19589286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.
    Törmäkangas L; Erkkilä L; Korhonen T; Tiirola T; Bloigu A; Saikku P; Leinonen M
    Infect Immun; 2005 Oct; 73(10):6458-66. PubMed ID: 16177317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model.
    Rupp J; Koch M; van Zandbergen G; Solbach W; Brandt E; Maass M
    FEMS Microbiol Lett; 2005 Jan; 242(2):203-8. PubMed ID: 15621438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae and cardiovascular disease.
    Campbell LA; Kuo CC; Grayston JT
    Emerg Infect Dis; 1998; 4(4):571-9. PubMed ID: 9866733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection.
    Kyläniemi MK; Haveri A; Vuola JM; Puolakkainen M; Lahesmaa R
    Microb Pathog; 2009 May; 46(5):235-42. PubMed ID: 19486640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology.
    Siscovick DS; Schwartz SM; Caps M; Wang SP; Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S417-20. PubMed ID: 10839727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chlamydia pneumoniae chronic infection in the development of arteriosclerosis].
    Nalepa P
    Pol Merkur Lekarski; 1998 May; 4(23):289-91. PubMed ID: 9825666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques.
    Fong IW; Chiu B; Viira E; Tucker W; Wood H; Peeling RW
    J Infect Dis; 2002 Nov; 186(10):1469-73. PubMed ID: 12404163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL.
    Dittrich R; Dragonas C; Mueller A; Maltaris T; Rupp J; Beckmann MW; Maass M
    Biochem Biophys Res Commun; 2004 Jun; 319(2):501-5. PubMed ID: 15178434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis, inflammation, and infection.
    de Boer OJ; van der Wal AC; Becker AE
    J Pathol; 2000 Feb; 190(3):237-43. PubMed ID: 10685058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between Chlamydia pneumoniae and atherosclerotic lesions of the aorta].
    Gloria Breceda F; Meaney Mendiolea E; Valero Elizondo G; Vela Huerta A
    Arch Inst Cardiol Mex; 1997; 67(1):17-23. PubMed ID: 9221706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.